Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments

Conditions

• Cancer
• Dermatologic Conditions

Eligibility Criteria

Sex

ALL

Age

3 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• Quality of Life (QoL) Assessment — BEHAVIORAL
  Per physician's discretion, the patient (or, if applicable, patient's family member/ spouse/ caregiver for FDLQI) will complete one or more of the following dermatology-specific QoL instruments: Skindex-16, Skindex-29 DLQI (Dermatology Life Quality Index), FDLQI (Family DLQI) - for patient's family member/spouse/caregiver ONLY, CDLQI (Children's DLQI;Cartoon version) - for patient's under the age of 18 ONLY-written, CDLQI (Children's DLQI; Cartoon version) - for patients under the age of 18 ONLY - cartoon version, FACT-G (Functional Assessment of Cancer Thearpy-General), FACT-Melanoma (Functional Assessment of Cancer Therapy-Melanoma), SCI (Skin Cancer Index) FACT-EGFRI-18 (Functional Assessment of Cancer Therapy-Epidermal Growth Factor Receptor Inhibitor-18), HFS-14 (Hand-Foot Syndrome) OMWQ (Oral Mucositis Weekly Questionnaire), ESTEEM, Hairdex , Skindex-29 modified for hair loss, Itchy QoL,CADS (Chemotherapy-induced alopecia distress scale)

Study Details

The purpose of this study is to see how skin conditions that are related to different kinds of cancer or cancer treatments affect a patient's overall well-being. Skin conditions are common in cancer patients and survivors. Sometimes, the skin condition is directly related to the cancer. Other times, these conditions are a side effect of cancer treatment. Patients in the study will be asked to fill out at least one questionnaire about how they feel about their skin condition. If the patient needs to be treated for their skin condition, they will be asked to complete the same questionnaire when they return for a follow-up visit. The investigators hope the study will improve our understanding of how cancer patients feel about their skin conditions. They also hope this study helps them learn how to improve the way we treat skin conditions in cancer patients.

Key Dates

Start date

Nov 18, 2014

Status verified

Dec 2025

Primary completion

Nov 30, 2026

Completion

Nov 30, 2026

Study Design

Enrollment

1,025 participants (estimated)

Arms

• Arm: Quality of Life (QoL) Assessment
  Patients involved in this study will have a wide range of dermatologic conditions for which they will be assessed and managed by the treating physician. An appropriate QoL instrument will be administered at the initial visit, and if applicable, at subsequent follow-up visit(s). Treatment of the dermatologic condition will be at physician's discretion based on the patient's presenting symptoms and is not an intervention itself within this study.

Primary Outcome Measure

Quality of Life (QoL) questionnaire [ Time Frame: 5 years ]

Central Contacts

• Erica Lee, MD
  646-888-6015
• Shamir Geller, MD
  [email protected]

Locations (4)

Find similar trials in Basking Ridge, NJ

Related Studies

• Effects of Oncological Treatment During Pregnancy on Mother and Child
  Recruiting · University Hospital, Gasthuisberg · Camden, New Jersey
• Childhood Cancer Survivor Study
  Recruiting · St. Jude Children's Research Hospital · Birmingham, Alabama
• Caris Biorepository Research Protocol
  Recruiting · Caris Science, Inc. · Mobile, Alabama
• Cryopreservation of Ovarian Tissue
  Recruiting · Weill Medical College of Cornell University · New York, New York